3LAU

Crystal Structure of Aurora2 kinase in complex with a GSK3beta inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.203 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.

Lesuisse, D.Dutruc-Rosset, G.Tiraboschi, G.Dreyer, M.K.Maignan, S.Chevalier, A.Halley, F.Bertrand, P.Burgevin, M.C.Quarteronet, D.Rooney, T.

(2010) Bioorg Med Chem Lett 20: 1985-1989

  • DOI: 10.1016/j.bmcl.2010.01.114
  • Primary Citation of Related Structures:  
    3LAU, 3LFN, 3LFQ, 3LFS

  • PubMed Abstract: 
  • From an HTS hit, a series of potent and selective inhibitors of GSK3beta have been designed based on a Cdk2-homology model and with the help of several crystal structures of the compounds within Cdk2.


    Organizational Affiliation

    Medicinal Chemistry, 13 Quai Jules Guesde, 94300 Vitry-sur-Seine, France. dominique.lesuisse@sanofi-aventis.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Serine/threonine-protein kinase 6A287Homo sapiensMutation(s): 1 
Gene Names: AIKARK1AURAAURKABTAKSTK15STK6AIRK1AYK1IAK1
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for O14965 (Homo sapiens)
Explore O14965 
Go to UniProtKB:  O14965
PHAROS:  O14965
GTEx:  ENSG00000087586 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO14965
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
OFI
Query on OFI

Download Ideal Coordinates CCD File 
B [auth A]N-[6-(4-hydroxyphenyl)-1H-indazol-3-yl]butanamide
C17 H17 N3 O2
VCIZMGNKKFEEHA-UHFFFAOYSA-N
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
OFI Binding MOAD:  3LAU IC50: 44 (nM) from 1 assay(s)
PDBBind:  3LAU IC50: 3.00e+4 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.203 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 48.07α = 90
b = 45.617β = 97.65
c = 59.561γ = 90
Software Package:
Software NamePurpose
AMoREphasing
CNSrefinement
DENZOdata reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2010-03-02
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2018-01-24
    Changes: Advisory, Structure summary
  • Version 1.3: 2021-10-13
    Changes: Advisory, Database references, Derived calculations